
    
      1. To identify prognostic factors of short and medium term mortality, by underlining the
           respective weights of organ dysfunction and characteristics of underlined malignancy

        2. Evaluate the health related quality of life of intensive care survivors(SF36)

        3. Impact of intensive care on families burden (HADS, IES).

        4. Assess clinicians' satisfaction ( intensivists, haematologists and intensive care
           nurses) in relation to medical decision-making.

        5. Establish the relevance of antifungal treatments.
    
  